Biotech

All Articles

Lundbeck signs $2.5 B check for Longboard as well as its epilepsy med

.After snooping blockbuster potential in Longboard Pharmaceuticals' epilepsy med, mind disease-focus...

Lilly selects UK for 1st Portal Lab in Europe

.Eli Lilly's Gateway Labs is actually going global, with the U.K. government announcing today that t...

Jasper dials up dose after hives reactions come and go quickly

.Jasper Rehab has reported complete feedbacks in 10 of the 12 persistent colonies patients who recei...

Transgene's viral cancer vaccine flunks midphase test

.Transgene's curative injection applicant TG4001 has flunked a stage 2 strong cyst trial. However, w...

Upstream swells IPO to $255M as it notes alongside CAMP4

.Upstream Biography has inflamed its own IPO to $255 million as the business joins CAMP4 Therapeutic...

Sanofi flunks MS research study, dealing another impact to Denali contract

.Sanofi has stopped a period 2 difficulty of Denali Therapeutics-partnered oditrasertib in multiple ...

Turnstone lays off 60%, agitates C-suite to extend money

.Turnstone Biologics is minimizing its own head count through 60% as well as shaking up its C-suite ...

Gilead loses hope on $15M MASH wager after weighing preclinical records

.In a year that has viewed a confirmation and also a boating of readouts for metabolic dysfunction-a...

Texas biotech centers cancer cells pact, pins hopes on obesity

.Alaunos Rehabs is actually axing a deal with Precigen, losing hope licensing legal rights to a cust...

Capricor portions more information for DMD treatment after initiating BLA

.Capricor Therapeutics is taking a success lap for their stage 2 Duchenne muscular dystrophy (DMD) t...